Algo version: 0.98b
Zimmer Biomet Holdings is listed at the SIX Exchange
Zimmer Biomet Holdings [ZBH.SW]
SIX Sector: Healthcare Industry:Medical Devices

Is Zimmer Biomet Holdings stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Zimmer Biomet Holdings pays dividends. Last time was Thursday 31st of October 2024 where the investors holding the stock on Monday 30th of September 2024 were paid CHF0.24 per share. Over the last 52 times between 2012 and 2024, Zimmer Biomet Holdings has paid CHF11.85369 with an average of CHF0.23 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Zimmer Biomet Holdings 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was CHF145.00, you would have made a loss of CHF-32.00 per share or -22.07%

We do not have enough data to give you this answer.

Zimmer Biomet Holdings has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.24, the company's ability to pay off the debt is normal. Zimmer Biomet Holdings has a good net profit margin of 14.27% and should have high tolerances against inflation.

We have calculated the inflation risk for Zimmer Biomet Holdings to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.